Scholar Rock Holding

Filed a patent for "selective and potent inhibitors of myostatin activation" on Thu, December 22, 2022

Filed a patent for "selective and potent inhibitors of myostatin activation" on Wed, December 28, 2022

Filed a patent for "tgf-beta inhibitors and therapeutic use thereof" on Tue, March 7, 2023

Filed a patent for "selective and potent inhibitors of myostatin activation" on Mon, July 24, 2023

Filed a patent for "selective and potent inhibitors of myostatin activation" on Thu, October 5, 2023

Filed a patent for "tgf-beta inhibitors and therapeutic use thereof" on Fri, October 13, 2023

Filed a patent for "compositions and methods for growth factor modulation" on Thu, November 7, 2024

Filed a patent for "a myostatin pathway inhibitor in combination with a glp-1 pathway activator for use in treating metabolic disorders" on Wed, December 20, 2023

Filed a patent for "use of anti-pro/latent myostatin antibody for treating spinal muscular atrophy" on Mon, June 20, 2022

Filed a patent for "tgfb inhibitors and use thereof" on Thu, February 23, 2023

Filed a patent for "tgf-beta inhibitors and use thereof" on Thu, February 16, 2023

Filed a patent for "use of anti-pro/latent myostatin antibody for treating spinal muscular atrophy" on Mon, October 10, 2022

Filed a patent for "therapies for weight management and related metabolic conditions" on Mon, March 21, 2022

Filed a patent for "ltbp complex-specific inhibitors of tgfb and uses thereof" on Thu, November 17, 2022